AU2002344611A1 - Method of diagnosing type 2 diabetes - Google Patents
Method of diagnosing type 2 diabetesInfo
- Publication number
- AU2002344611A1 AU2002344611A1 AU2002344611A AU2002344611A AU2002344611A1 AU 2002344611 A1 AU2002344611 A1 AU 2002344611A1 AU 2002344611 A AU2002344611 A AU 2002344611A AU 2002344611 A AU2002344611 A AU 2002344611A AU 2002344611 A1 AU2002344611 A1 AU 2002344611A1
- Authority
- AU
- Australia
- Prior art keywords
- diabetes
- diagnosing type
- diagnosing
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2002/011306 WO2004040301A1 (en) | 2002-10-30 | 2002-10-30 | Method of diagnosing type 2 diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002344611A1 true AU2002344611A1 (en) | 2004-05-25 |
Family
ID=32260018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002344611A Abandoned AU2002344611A1 (en) | 2002-10-30 | 2002-10-30 | Method of diagnosing type 2 diabetes |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP4214235B2 (en) |
| AU (1) | AU2002344611A1 (en) |
| WO (1) | WO2004040301A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007082458A (en) * | 2005-09-21 | 2007-04-05 | Hokkaido Univ | Diagnosis method for type 2 diabetes |
| JP2009207354A (en) * | 2006-10-19 | 2009-09-17 | Dna Chip Research Inc | Method for determining presence or absence, or the like diabetes |
| SE534386C2 (en) | 2009-10-29 | 2011-08-02 | Alfa Laval Corp Ab | Centrifugal separator and method for separating solid particles |
-
2002
- 2002-10-30 AU AU2002344611A patent/AU2002344611A1/en not_active Abandoned
- 2002-10-30 WO PCT/JP2002/011306 patent/WO2004040301A1/en not_active Ceased
- 2002-10-30 JP JP2004547992A patent/JP4214235B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4214235B2 (en) | 2009-01-28 |
| WO2004040301A1 (en) | 2004-05-13 |
| JPWO2004040301A1 (en) | 2006-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003276045A1 (en) | Method of solving a split-brain condition | |
| AU2003282548A1 (en) | Nano-chem-fet based biosensors | |
| AU2003240093A1 (en) | Lancet | |
| AU2003221808A1 (en) | Analyte sensor | |
| AU2003225690A1 (en) | Mycobacterial diagnostics | |
| AU2003251955A1 (en) | Platinum compound | |
| AU2003219359A1 (en) | Imaging method | |
| AU2003277596A1 (en) | Method of deuterization | |
| AU2002328630A1 (en) | Method of diagnosing or monitoring saccharometabolic error | |
| AU2003232823A1 (en) | Electrochemical biosensor | |
| AU2003221195A1 (en) | Method of diagnosing risk of myocardial infarction | |
| AU2003206272A1 (en) | Method of image analysis | |
| AU2003242340A1 (en) | Novel screening method | |
| AU2003223780A1 (en) | Treatment for pompe disease | |
| AU2003224917A1 (en) | Diabetes imaging probes | |
| AU2002344611A1 (en) | Method of diagnosing type 2 diabetes | |
| AU2002323855A1 (en) | Method for diagnosing the functional condition of an organism | |
| AU2003294206A1 (en) | Methods for diagnosing htlv-i-mediated diseases | |
| AU2003294117A1 (en) | Suturing method | |
| AU2003249935A1 (en) | Method for the production of electrically-conducting connections on chipcards | |
| AU2003289566A1 (en) | Preparation method of 1,5-dimethyltetralin | |
| AU2003255823A1 (en) | Diagnostic test | |
| AU2003242342A1 (en) | Novel screening method | |
| AUPS306402A0 (en) | Assay method | |
| AU2003227940A1 (en) | Viscometers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |